About Ternion Biosciences

Ternion is a Singapore biotech startup CRO with aims to disrupt the conventional approach to pre-clinical drug safety testing and pharmacovigilance. Ternion's OptioQUANT platform-assay is very much faster, with higher throughput using human stem cell based assays. Compared to the use of animal based studies, OptioQUANT provides more physiologically relevant, efficient and cost effective studies. Ternion's expertise include human stem cells, tissue engineering, ion channels, electrophysiology andView more